31-Gene Expression Profile Testing Survival Benefit in a Population-based Analysis of Cutaneous Melanoma Patients ≥65 Years of Age. (2022). SKIN The Journal of Cutaneous Medicine, 6(2), s24. https://doi.org/10.25251/skin.6.supp.24